Efficacy of rotigotine as measured by individual Unified Parkinson’s Disease Rating Scale II and III items: a post-hoc analysis
Objective: The key aim was to assess the efficacy of rotigotine (RTG) transdermal patch on individual items of Unified Parkinson’s Disease Rating Scale (UPDRS) II…The landscape of interventional trials in Parkinson disease: A 10-year review of ClinicalTrials.gov between 2006 and 2016
Objective: To review the scope of interventional trials for Parkinson disease registered on clinicaltrials.gov in the past 10 years. Background: Parkinson disease (PD) is a broad chronic condition…How will new technology change deep brain stimulation programming?
Objective: Assess the ways in which decision support tools and directional leads are affecting DBS programming. Background: The typical approach to DBS programming has changed…Voice Therapy Normalizes Feedforward and Feedback Networks of the Speech Motor System
Objective: The aim of the study was to isolate the specific effects of the training target of The Lee Silverman Voice Therapy (LSVT) in Parkinson’s…Study in Parkinson’s Disease of Exercise (SPARX): A Randomized, Controlled Futility Trial
Objective: Our first objective was to determine whether people with de novo Parkinson’s disease (PD) are able to exercise at either 60-65% maximal heart rate…Four year outcomes of a prospective, multi-center trial evaluating Deep Brain Stimulation with a new multiple-source, constant-current rechargeable system in Parkinson’s disease
Objective: To evaluate the four year, long-term follow up results of patients in the VANTAGE clinical study that employed multiple independent current control (MICC) Deep Brain…Istradefylline improves not only motor symptoms but also sleep disturbance, daytime sleepiness, and QOL of Parkinson’s disease patients.
Objective: This study analyzed the clinical effectiveness of istradefylline in terms of sleep disturbance in Parkinson’s disease (PD) patients. Background: A selective adenosine A2A receptor…Improving Racial and Ethnic Diversity in Parkinson`s Disease Clinical Trials
Objective: To identify and overcome challenges to recruiting minorities in Parkinson's Disease experimental therapeutic trials. Background: Inadequate representation of ethnic and minority population poses substantial…Deep brain stimulation in Parkinson’s disease: Outcome after more than nine years
Objective: The aim of this study is to examine the long-term effects of deep brain stimulation of the subthalamic nucleus (STN DBS) in Parkinson’s disease…Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
Objective: The purpose of this study was to identify potential plasma metabolic biomarkers for Parkinson’s disease (PD) Background: PD, characterized by a slowness of movement…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.